BGM Group (NASDAQ:BGM) Shares Gap Up – Should You Buy?

BGM Group Ltd. (NASDAQ:BGM)’s stock price gapped up before the market opened on Friday . The stock had previously closed at $9.18, but opened at $9.50. BGM Group shares last traded at $9.2750, with a volume of 18,277 shares traded.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d)” rating on shares of BGM Group in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

BGM Group Stock Performance

The company’s 50-day simple moving average is $9.33 and its 200 day simple moving average is $10.22.

Hedge Funds Weigh In On BGM Group

An institutional investor recently bought a new position in BGM Group stock. Marshall Wace LLP acquired a new stake in shares of BGM Group Ltd. (NASDAQ:BGM) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 20,632 shares of the company’s stock, valued at approximately $218,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.